Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
SRTS

SRTS - Sensus Healthcare Inc Stock Price, Fair Value and News

$5.11+0.07 (+1.39%)
Market Closed

55/100

SRTS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

55/100

SRTS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$5.42

Target 3M

$4.97

Target 6M

$5.11

SRTS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SRTS Price Action

Last 7 days

3.0%

Last 30 days

35.9%

Last 90 days

60.7%

Trailing 12 Months

-26.2%

SRTS RSI Chart

SRTS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SRTS Valuation

Market Cap

83.9M

Price/Earnings (Trailing)

-27.92

Price/Sales (Trailing)

2.36

EV/EBITDA

-10.39

Price/Free Cashflow

38.73

SRTS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$5.42

Target 3M

$4.97

Target 6M

$5.11

SRTS Fundamentals

SRTS Revenue

Revenue (TTM)

35.6M

Rev. Growth (Yr)

-22.12%

Rev. Growth (Qtr)

-5.89%

SRTS Earnings

Earnings (TTM)

-3.0M

Earnings Growth (Yr)

-177.61%

Earnings Growth (Qtr)

9.06%

SRTS Profitability

Operating Margin

68.46%

EBT Margin

-13.13%

Return on Equity

-5.87%

Return on Assets

-5.16%

Free Cashflow Yield

2.58%

SRTS Investor Care

Shares Dilution (1Y)

0.21%

Diluted EPS (TTM)

-0.18

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202539.5M37.6M35.6M0
202431.7M36.4M41.3M41.8M
202337.6M30.1M24.9M24.4M
202231.4M35.8M40.2M44.5M
202111.0M0027.0M
202023.5M17.2M13.0M9.6M
201925.9M27.3M26.8M27.3M
201822.2M23.3M24.8M26.4M
201716.1M17.5M19.0M20.6M
201611.4M12.5M13.7M14.8M
201500010.3M
Get all data in R, Python etc through our Historical Stock Data APIs

About Sensus Healthcare Inc

SRTS
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and TransDermal Infusion system. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body, as well as distributes laser devices. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
 CEO
 WEBSITEsensushealthcare.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES42

Sensus Healthcare Inc Frequently Asked Questions

SRTS is the stock ticker symbol of Sensus Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Sensus Healthcare Inc is 83.93 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check SRTS's fair value in chart for subscribers.

The fair value guage provides a quick view whether SRTS is over valued or under valued. Whether Sensus Healthcare Inc is cheap or expensive depends on the assumptions which impact Sensus Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SRTS.

As of Wed Jan 28 2026, SRTS's PE ratio (Price to Earnings) is -27.92 and Price to Sales (PS) ratio is 2.36. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SRTS PE ratio will change depending on the future growth rate expectations of investors.